Trial Profile
Protective Role of Inhaled Steroids for Covid-19 Infection
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms INHASCO
- 31 Jul 2021 Status changed from active, no longer recruiting to discontinued due to insufficient recruitment.
- 14 May 2021 Status changed from discontinued to active, no longer recruiting.
- 14 May 2021 Planned number of patients changed from 872 to 436.